- Filed
- May 4, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2020 · Mar 31, 2020 | 16.63M sh |
| Shares Diluted restated | Q1 2020 · Mar 31, 2019 | 16.91M sh |
| Stock Repurchased | Q1 2020 · Mar 31, 2020 | $707K |
| Stock Repurchased | Q1 2020 · Mar 31, 2019 | $1.39M |
| Capex | Q1 2020 · Mar 31, 2020 | $877K |
| Capex restated | Q1 2020 · Mar 31, 2019 | $901K |
| Operating Cash Flow | Q1 2020 · Mar 31, 2020 | $11.58M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2019 | $10.92M |
| Long Term Debt | Q1 2020 · Mar 31, 2020 | $297.48M |
| Long Term Debt | Q1 2020 · Dec 31, 2019 | $299.57M |
| Short Term Debt | Q1 2020 · Mar 31, 2020 | $13.74M |
| Short Term Debt | Q1 2020 · Dec 31, 2019 | $16.98M |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $107.05M |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $105.84M |
| Cash And Equivalents restated | Q1 2020 · Mar 31, 2019 | $9.95M |
| Cash And Equivalents restated | Q1 2020 · Dec 31, 2018 | $15.61M |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | $41.68M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | $46.97M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $62.52M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $91.77M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $382.35M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $410.8M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $199.81M |
| Current Assets | Q1 2020 · Dec 31, 2019 | $234.37M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $476.44M |
| Total Assets | Q1 2020 · Dec 31, 2019 | $511.05M |
| Eps Diluted | Q1 2020 · Mar 31, 2020 | −$0.20 |
| Eps Diluted | Q1 2020 · Mar 31, 2019 | −$0.21 |
| Eps Basic | Q1 2020 · Mar 31, 2020 | −$0.20 |
| Eps Basic | Q1 2020 · Mar 31, 2019 | −$0.21 |
| Sga Expense | Q1 2020 · Mar 31, 2020 | $34.78M |
| Sga Expense | Q1 2020 · Mar 31, 2019 | $30.73M |
| Net Income | Q1 2020 · Mar 31, 2020 | −$3.32M |
| Net Income | Q1 2020 · Mar 31, 2019 | −$3.54M |
| Operating Income | Q1 2020 · Mar 31, 2020 | $6.66M |
| Operating Income restated | Q1 2020 · Mar 31, 2019 | $9.79M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2020 | $49.93M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2019 | $51.78M |
| Revenue | Q1 2020 · Mar 31, 2020 | $91.37M |
| Revenue restated | Q1 2020 · Mar 31, 2019 | $92.31M |